Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07201649

Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
95 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Individuals with metabolic syndrome (MetS), particularly those with type 2 diabetes (T2D), and/or metabolic dysfunction-associated steatohepatitis or MASH face an elevated risk of major cardiovascular events (MACE). We showed decrease plams level of PPi in patients with liver cirrhosis. We hypothezised that liver transplant should block AC and restore PPi plasma level.

Conditions

Interventions

TypeNameDescription
OTHERa blood test and urine sample collection.The study is offered to all patients who meet the inclusion criteria during their pre-transplant assessment by the principal investigator (during an existing visit). Patients eligible for HT are contacted by a clinical research coordinator, and if they agree, an inclusion visit is arranged.

Timeline

Start date
2025-11-24
Primary completion
2028-11-24
Completion
2029-11-24
First posted
2025-10-01
Last updated
2025-12-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07201649. Inclusion in this directory is not an endorsement.